NASDAQ: AKTX       Akari Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
3.00   +0.06 (2.04%)  2.67 - 3.08  195,550


Avg Volume (4 weeks):399,950
4 Weeks Range:1.771 - 3.76
4 Weeks Price Volatility (%):
52 Weeks Range:0.87 - 3.76
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system for the treatment of rare and orphan diseases. Its main product candidate includes Coversin, Coversin long acting and Coversin dual action. The firm earns majority of its revenues from United Kingdom. It operates mainly in United States and United Kingdom.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2251  4137  260  3248 

Top 10 Active Counters
 AMC 4.31+0.80 
 BB 16.87+2.83 
 EXPR 3.67+1.88 
 NOK 4.737+0.537 
 SNDL 0.591-0.054 
 LK 1.38+1.38 
 PLTR 32.59+0.01 
 CTRM 0.378-0.027 
 GME 69.969+4.959 
 WPX 9.43+0.48